The number of cases employing thoracic endovascular aortic repair (TEVAR) has been increasing due to lower morbidity and mortality compared to open repair technique. The aim of this study is to evaluate the outcome of TEVAR for thoracic aortic diseases. Materials and Methods: Sixteen patients underwent TEVAR from October 2003 to April 2010. Mean age at operation was 59 years (20∼78 years), and 11 were male. Indications for TEVAR were large aortic diameter (＞5.5 cm) upon presentation in 6 patients, increasing aortic diameter during the follow-up period in 4, traumatic aortic rupture in 3, persistent chest pain in 2, and ruptured aortic aneurysm in one. The mean diameter, length and the number of the stents were 33 mm (26∼40 mm), 12 cm (9.5∼16.0 cm), and 1.25 (1∼2), respectively. Aortography employing Multi-detector computerized tomography (MDCT) technique was performed at one week, and patients were followed up in the out-patient department at one month, 6 months, and one year postoperatively. Results: Primary technical success showing complete exclusion of the aneurysm was achieved in 15 patients. One patient showed a small endo-leak (type 1). Four patients developed perioperative stroke: Three recovered without sequelae, and one showed mild right-side weakness. There was no operative mortality. Diameter of the thoracic aorta covered by stent graft changed within 10% range in 12 patients, decreased by more than 10% in 3, and increased by more than 10% in one during mean follow-up duration of 18 months (1∼ 73 months). There was no recurrence-related death during this period. Conclusion: Intermediate-term outcome after TEVAR was encouraging. Indications for TEVAR could be extended for other thoracic aortic diseases.
INTRODUCTION
After stent graft implantation became a standard procedure for infra-renal abdominal aortic aneurysm, the number of cases of thoracic endovascular aortic repair (TEVAR) in Korea has been rapidly increasing [1] [2] [3] [2] . Furterhmore, when the application of TEVAR for aortic arch aneurysm is difficult because proximal landing zone (PLZ) for stent graft overrides the origin of the arch vessels, hybrid procedure (i.e. surgical debranching of the arch vessels plus TEVAR) has been recently developed [3] .
In this study, we sought to determine the intermediate-term
results of TEVAR for thoracic aortic aneurysm. 
MATERIALS AND METHODS

RESULTS
Endovascular aneurismal exclusion was confirmed in 15
patients (15/16, 94%). One patient showed minimal Type 1 endoleak, and has been closely followed up ever since the procedure without further deterioration. Cerebral embolism occurred in four patients: Three recovered completely, and one developed mild right side motor weakness. Two patients developed left-sided pleural effusion, which was drained using a catheter in one. There was no surgical mortality.
During a mean follow-up duration of 18 months (1∼73 months), the diameter of the thoracic aorta covered by the stent graft changed within 10% range in 12 patients, decreased by more than 10% in 3, and increased by more than 10% in one (Fig. 3) . There was no late death related to the recurrence of the original aortic disease.
DISCUSSION
Stent graft TEVAR for various thoracic aortic diseases reportedly shows low morbidity and mortality compared to conventional surgical approach [1] [2] [3] [4] . Technical success rate of TEVAR (i.e. complete isolation of the anurtysmal cavity from the aortic circulation) has reached up to 98%, while early mortality (1.9∼2.9%) is extremely lower than that (5.7∼
11.7%) of surgical series [2] [3] [4] . As for the morbidity, a recent report claimed that TEVAR resulted in lower incidence Traumatic aortic rupture is caused by an acute deceleration injury on the insertion site of ligamentum arteriosum, and frequently associated with multiple trauma, which may render the surgical outcome even worse. In this setting, TEVAR is a formidable alternative to a surgical intervention by minimizing the invasiveness of the repair [5] . Small sized stent grafts tend to be used for TEVAR for patients with traumatic aortic rupture because this condition frequently occurs in younger population whose pre-trauma aortic size could well be normal.
With respect to the outcome after TEVAR for uncomplicated type B dissection, INSTEAD (Investigation of stent graft in patients with type B aortic dissection) study conducted in Europe showed that there was no difference in 1 year survival between TEVAR group and medical treatment group [6] . However, given that the size of the aorta increases as time passes, the longer term outcome may turn out to be in favor of TEVAR strategy [7] . To the contrary, Iris et al observed that there was no difference in the size of the false aortic lumen between TEVAR and medical treatment groups, and they asserted that TEVAR procedure never abolishes, albeit may delay, the manifestation of the adverse outcome from the natural progression of the aortic disease [8] . In our series, there was one patient whose aortic diameter increased as time passed.
As for chronic aortic dissection, partial thrombus formation in the false lumen is believed to increase the risk of rupture and death [9] . Thus, the benefits from TEVAR in comparison to surgical approach is still controversial, because stent graft only obliterates the opening of the entry site while leaving reentry site uncovered, which may end up with partial thrombus formation, progressive aortic dilation and rupture of the thoracic aorta.
Surgical correction of acute type B dissection involving the origin of arch vessels is associated with significant morbidity and high mortality rate [10] . Arch vessels obstruction is caused by intimal flap occluding the origins of the vessels, and obstruction can be either static (i.e. fixed obstruction) or dynamic (i.e. intermittent obstruction according to the cardiac cycle) [11] . Arch dissection with static obstruction of the arch vessels necessitate self-expandable stent insertion into the arch vessels, and communication between the true lumen and arch vessel origins is established either by fenestration of the stent graft or by the use of separate bare stent at the arch level. On the contrary, arch dissection with dynamic obstruction of the arch vessels only requires obliteration of the entry site by stent graft so that intermittent expansion of the initmal flap during the systolic phase is prevented [11] . Early and late mortality after surgery for patients who had undergone TEVAR for arch dissection with arch vessel obstruction are reported to be 17% and 36%, respectively, which appears to be much better than the mortality after conventional surgical repair for acute arch dissection (40%) [11] . This finding signifies that the application of TEVAR to arch dissection is designed to convert a complicated type B dissection involving arch vessels into an uncomplicated chronic type B dissection, which is much more amenable to a surgical intervention. In this regards, Szeto et al asserted that TEVAR should be considered as the fist-line treatment for complicated type B acute dissection (i.e. rupture or arch obstruction), evidenced by the low procedure-related mortality (3%) in 35 patients with complicated arch dissection [12] . However, some argue that the risk of false lumen rupture in type-B dissection with arch vessel obstruction remains significant even after TEVAR is performed [13] . As for uncomplicated type B dissection, ADSORB (Acute Uncomplicated Aortic Dissection Type B:
Evaluating Stent-Graft Placement or Best Medical Treatment Alone) study has investigated on the benefits of stent graft over medical treatment, which has not reached a conclusion yet. Timing of TEVAR for type B acute dissection is also controversial. Some prefer to delay the procedure to 2∼4
weeks after the onset, based on the findings that intimal flap is fragile and easily breakable during early period [14, 15] , while others believe that early intervention may promote the complete restoration of the aortic integrity, and thus could − 152 − improve the long-term outcome [16, 17] . In a study which compared the outcomes after TEVAR and medical treatment for acute type B dissection [10] , the authors insisted that there was no difference in the development of complication or mortality, and therefore TEVAR should be reserved only for complicated type B dissection. Akira et al stratified the patients according to the diameter of the aorta, and they concluded that TEVAR should be indicated for patients whose maximal aortic diameter is greater than 40 mm, based on their observations that 60% of the patients with large aorta (≥40 mm in diameter) showed enlargement of the false lumen and underwent a surgical intervention while 94% of the patients with small aorta (≤40 mm in diameter) showed spontaneous obliteration of the false lumen [18] .
Preoperative computed tomographic angiography can be Postoperative evaluation is based on the findings of MDCT, which is to be performed at postoperative 1,6 and 12 months, and annually from that on. If type 1 endo-leak is detected on MDCT, immediate intervention is recommended, and, if type 2 endo-leak is suspected, close follow-up focusing on the size change of the aneurysm is suggested.
The application of TEVAR using stent graft has not been fully established yet. Traumatic aortic rupture and descending thoracic aneurysm seem to be best benefitted from this new therapeutic modality, and TEVAR is expected to rapidly replace the conventional surgical approach. As for aortic arch dissection involving arch vessels, employment of hybrid procedure (i.e. TEVAR with surgical interventions for arch vessels) will increase [3] . The efficacy of TEVAR for acute type B dissection is still under debate: Some are insisting that TEVAR does not change the natural course of the false lumen while others claim that TEVAR may contribute to the regression of the false lumen by thrombus formation and absorption [8, 19] . Thus, further study with longer-term follow-up is necessary to delineate the benefits from TEVAR for this subset.
CONCLUSION
Intermediate-term outcome after TEVAR was encouraging.
Indications for TEVAR could be extended for other thoracic aortic diseases.
